Global Plasma Fractionation Market Overview 2023-2028
IMARC Group, a leading market research company, has recently releases report titled “Plasma Fractionation Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global plasma fractionation market trends, size, share, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
The global plasma fractionation market size reached US$ 23.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 33.7 Billion by 2028, exhibiting a growth rate (CAGR) of 5.8% during 2023-2028.
Plasma fractionation involves the separation of plasma into its various individual components, such as proteins, clotting factors, and immunoglobulins. It plays an essential role in ensuring a stable supply of essential plasma-derived medicines, contributing significantly to the well-being of patients. It isolates and purifies specific plasma proteins for therapeutic and medical purposes. It is vital in managing conditions, such as massive bleeding or clotting disorders, and provides crucial support in critical care situations and helping stabilize patients during medical emergencies. It is essential in therapies for neurological disorders, including Alzheimer's disease, multiple sclerosis, and Guillain-Barré syndrome. It serves as a key role in developing therapies for rare and orphan diseases and providing treatment options for individuals with conditions that have limited treatment alternatives. It supports medical research by offering purified plasma components for studies and experiments, leading to advancements in understanding diseases and developing new treatments. It is beneficial for burn injuries and trauma cases to maintain proper fluid balance, promote clotting, and support tissue repair. It aids in reducing the risk of shortage of medicines and ensuring that patients with chronic conditions have access to the therapies they need. As it is beneficial in increasing the chances of survival of patients suffering from various diseases, the demand for plasma fractionation is increasing around the world.
Request a Sample Report:- https://www.imarcgroup.com/plasma-fractionation-market/requestsample
Global Plasma Fractionation Market Trends and Drivers:
The rising adoption of plasma fractionation to treat various medical conditions, such as hemophilia, autoimmune diseases, and neurological diseases, among the masses across the globe currently represents one of the primary factors impelling the market growth. In line with this, the escalating demand for plasma-derived therapies, such as convalescent plasma, for treating infectious diseases, along with the increasing focus on early detection of diseases among people, is positively influencing the market. Additionally, the rising utilization of advanced plasma fractionation equipment that offers increased efficiency and reduced costs, is supporting the growth of the market. Apart from this, there is an increase in demand for plasma fractionation to develop therapies for rare and orphan diseases. This, coupled with the rising adoption of plasma fractionation due to the improving healthcare infrastructure facilities around the world, is strengthening the market growth. Besides this, advancements in plasma fractionation techniques and technologies assist in the development of safer, more efficient, and higher-quality plasma-derived products, which is propelling the market growth. In addition, the increasing awareness among healthcare professionals and patients about the effectiveness of plasma-derived therapies is offering lucrative growth opportunities to industry investors. Furthermore, the growing demand for plasma-fractionation on account of rising incidences of age-related conditions that require plasma-derived treatments, such as Alzheimer's disease and certain neurological disorders, is offering a positive market outlook. Moreover, governing agencies of numerous countries are promoting voluntary blood donation campaigns, which is contributing to the growth of the market.
Global Plasma Fractionation Market 2023-2028 Analysis and Segmentation:
Top Key Players covered in this report are: ADMA Biologics, Bio Products Laboratory Ltd., Boccard, Grifols, S.A., Hemarus Therapeutics Limited, Intas Pharmaceuticals Limited, LFB S.A., Merck Group, Octapharma AG, PlasmaGen BioSciences Pvt. Ltd., SK Plasma Co. Ltd. and Virchow Biotech Private Limited
The report segmented the market on the basis of region, product, sector, application and end user.
Breakup by Product:
- Immunoglobulins
- Albumin
- Coagulation factor VIII
- Coagulation factor IX
Breakup by Sector:
- Private Sector
- Public Sector
Breakup by Application:
- Neurology
- Immunology
- Hematology
- Other Applications
Breakup by End User:
- Hospitals and Clinics
- Clinical Research Laboratories
- Academic Institutes
Breakup By Regions:
- North America: (United States, Canada)
- Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
Key highlights of the report:
- Market Performance (2017-2022)
- Market Outlook (2023- 2028)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Services Private Limited.
134 N 4th St. Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
